Welcome to our dedicated page for Bio-Key Intl news (Ticker: BKYI), a resource for investors and traders seeking the latest updates and insights on Bio-Key Intl stock.
BIO-key International, Inc. reports developments in identity and access management software, biometric authentication technology, and related security hardware. The company’s updates center on cloud-hosted and on-premise PortalGuard IAM, biometric-centric multi-factor authentication, Passkey:YOU, and devices such as Pocket 10 Finger Scanners and Mobile POS Pro. Customer news includes software license renewals, public-sector channel partnerships, defense deployments, and retail-bank biometric identification programs.
Financial and corporate updates also cover operating results, revenue contributions from services, license fees, and hardware, Nasdaq listing compliance, periodic-report timing, and share-structure actions such as the company’s 1-for-10 reverse stock split.
BIO-key International, Inc. (BKYI) announced the sale of a $2,415,400 Senior Secured Convertible Note to Lind Global Macro Fund, LP. Out of this amount, $2.1 million was funded, aimed at general working capital and repaying outstanding debt. The note is secured by a first priority lien on BIO-key’s assets and can be converted into shares at $1.16 each. The principal is due in five installments, starting seven months post-funding. The investor also received a five-year warrant for 1,900,000 shares at the same conversion price. The CEO emphasized the financing will support growth amid current economic challenges.